Document Detail


Drug use in pregnancy; a point to ponder!
MedLine Citation:
PMID:  20177448     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Pregnancy is a special physiological condition where drug treatment presents a special concern because the physiology of pregnancy affects the pharmacokinetics of medications used and certain medications can reach the fetus and cause harm. Total avoidance of pharmacological treatment in pregnancy is not possible and may be dangerous because some women enter pregnancy with medical conditions that require ongoing and episodic treatment (e.g. asthma, epilepsy, hypertension). Also during pregnancy new medical problems can develop and old ones can be exacerbated (e.g. migraine, headache) requiring pharmacological therapy. The fact that certain drugs given during pregnancy may prove harmful to the unborn child is one of the classical problems in medical treatment. In 1960's pregnant ladies who ingested thalidomide gave birth to children with phocomalia. Various other examples of teratogenic effects of drugs are known. It has been documented that congenital abnormalities caused by human teratogenic drugs account for less than 1% of total congenital abnormalities. Hence in 1979, Food and Drug Administration developed a system that determines the teratogenic risk of drugs by considering the quality of data from animal and human studies. FDA classifies various drugs used in pregnancy into five categories, categories A, B, C, D and X. Category A is considered the safest category and category X is absolutely contraindicated in pregnancy. This provides therapeutic guidance for the clinician. This article focuses on various aspects relating to drug use during pregnancy.
Authors:
Punam Sachdeva; B G Patel; B K Patel
Related Documents :
17587258 - Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics.
7136638 - Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspr...
11934528 - The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures.
12899868 - Levetiracetam monotherapy during pregnancy: a case series.
24357638 - Toxic effects of maternal zearalenone exposure on uterine capacity and fetal developmen...
97478 - Air caloric stimulation with tympanic membrane perforation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Indian journal of pharmaceutical sciences     Volume:  71     ISSN:  1998-3743     ISO Abbreviation:  Indian J Pharm Sci     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2010-02-23     Completed Date:  2011-07-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  7809431     Medline TA:  Indian J Pharm Sci     Country:  India    
Other Details:
Languages:  eng     Pagination:  1-7     Citation Subset:  -    
Affiliation:
Department of Pharmacology, A. R. College of Pharmacy, Vallabh Vidyanagar-388 120, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ischiopagus tetrapus conjoined twins: 22 years after separation.
Next Document:  Spectroscopic and electrochemical analysis of psychotropic drugs.